Literature DB >> 12189451

Effects of cisapride on colonic transit in patients with progressive systemic sclerosis.

S-J Wang1, J-L Lan, J-L Lan, D-Y Chen, Y-H Chen, T-Y Hsieh, W-Y Lin.   

Abstract

Progressive systemic sclerosis (PSS) may involve any portion of the gastrointestinal tract, including the colon. Constipation is common in patients with PSS. Cisapride, a benzamide derivative, is a potentially useful agent in the treatment of chronic idiopathic constipation. The effect of cisapride on colonic transit was evaluated in 16 PSS patients by a radionuclide colonic transit method. Each patient received cisapride orally three times a day for a week. The results showed acceleration in colonic transit in response to cisapride. We conclude that cisapride is effective in the treatment of constipation in patients with PSS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189451     DOI: 10.1007/s100670200072

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

1.  Gastrojejunostomy and duodenojejunostomy for megaduodenum in systemic sclerosis sine scleroderma: report of a case.

Authors:  Katsuyoshi Kudoh; Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Ken-Ichi Takahashi; Hitoshi Ogawa; Yasuhiro Sagami; Yasuhiko Hirabayashi; Takuya Moriya; Iwao Sasaki
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

2.  Gastrointestinal manifestations in Hungarian scleroderma patients.

Authors:  Szilvia Szamosi; Zoltán Szekanecz; Gabriella Szucs
Journal:  Rheumatol Int       Date:  2006-06-13       Impact factor: 2.631

3.  Profile of gastrointestinal involvement in patients with systemic sclerosis.

Authors:  T Schmeiser; P Saar; D Jin; M Noethe; A Müller; N Soydan; P D Hardt; C Jaeger; O Distler; E Roeb; R G Bretzel; U Müller-Ladner
Journal:  Rheumatol Int       Date:  2011-07-19       Impact factor: 2.631

4.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Andrew B Shreiner; Charles Murray; Christopher Denton; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-10-18

Review 5.  Intestinal Involvement in Systemic Sclerosis: A Clinical Review.

Authors:  Lazaros I Sakkas; Theodora Simopoulou; Dimitrios Daoussis; Stamatis-Nick Liossis; Spyros Potamianos
Journal:  Dig Dis Sci       Date:  2018-02-21       Impact factor: 3.199

Review 6.  Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis.

Authors:  Daniel E Furst; Yolanda Braun-Moscovic; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

Review 7.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  Robyn Domsic; Kenneth Fasanella; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

8.  Anorectal motility and sensation abnormalities and its correlation with anorectal symptoms in patients with systemic sclerosis: a preliminary study.

Authors:  Hanaa S Sallam; Terry A McNearney; Jiande Z Chen
Journal:  ISRN Gastroenterol       Date:  2011-06-06

Review 9.  A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-03-04       Impact factor: 4.991

10.  Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma.

Authors:  Agostino Di Ciaula; Michele Covelli; Massimo Berardino; David Q H Wang; Giovanni Lapadula; Giuseppe Palasciano; Piero Portincasa
Journal:  BMC Gastroenterol       Date:  2008-02-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.